Annual EBIT
-$27.12 M
-$40.77 M-298.78%
31 December 2023
Summary:
Arcturus Therapeutics Holdings annual earnings before interest & taxes is currently -$27.12 million, with the most recent change of -$40.77 million (-298.78%) on 31 December 2023. During the last 3 years, it has risen by +$44.19 million (+61.97%). ARCT annual EBIT is now -298.78% below its all-time high of $15.17 million.ARCT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$10.74 M
+$6.63 M+38.17%
30 September 2024
Summary:
Arcturus Therapeutics Holdings quarterly earnings before interest & taxes is currently -$10.74 million, with the most recent change of +$6.63 million (+38.17%) on 30 September 2024. Over the past year, it has increased by +$8.58 million (+44.41%). ARCT quarterly EBIT is now -108.99% below its all-time high of $119.43 million, reached on 31 December 2022.ARCT Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$21.74 M
+$8.58 M+28.29%
30 September 2024
Summary:
Arcturus Therapeutics Holdings TTM earnings before interest & taxes is currently -$21.74 million, with the most recent change of +$8.58 million (+28.29%) on 30 September 2024. Over the past year, it has dropped by -$121.49 million (-121.80%). ARCT TTM EBIT is now -118.79% below its all-time high of $115.70 million, reached on 31 March 2023.ARCT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARCT EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -298.8% | +44.4% | -121.8% |
| 3 y3 years | +62.0% | +79.9% | +88.8% |
| 5 y5 years | -25.6% | -48.5% | -42.9% |
ARCT EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -298.8% | +86.6% | -109.0% | +79.9% | -118.8% | +89.3% |
| 5 y | 5 years | -298.8% | +86.6% | -109.0% | +80.8% | -118.8% | +89.3% |
| alltime | all time | -298.8% | +86.6% | -109.0% | +80.8% | -118.8% | +89.3% |
Arcturus Therapeutics Holdings EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$10.74 M(-38.2%) | -$21.74 M(-28.3%) |
| June 2024 | - | -$17.37 M(-34.3%) | -$30.32 M(-53.3%) |
| Mar 2024 | - | -$26.45 M(-180.6%) | -$64.93 M(-594.7%) |
| Dec 2023 | -$27.12 M(-298.8%) | $32.81 M(-269.9%) | $13.12 M(-86.8%) |
| Sept 2023 | - | -$19.31 M(-62.8%) | $99.75 M(+18.0%) |
| June 2023 | - | -$51.97 M(-200.7%) | $84.56 M(-26.9%) |
| Mar 2023 | - | $51.60 M(-56.8%) | $115.70 M(+747.9%) |
| Dec 2022 | $13.64 M(-106.7%) | $119.43 M(-446.2%) | $13.64 M(-109.4%) |
| Sept 2022 | - | -$34.50 M(+65.6%) | -$145.59 M(-11.5%) |
| June 2022 | - | -$20.84 M(-58.7%) | -$164.47 M(-16.7%) |
| Mar 2022 | - | -$50.45 M(+26.7%) | -$197.50 M(-2.6%) |
| Dec 2021 | -$202.85 M(+184.4%) | -$39.81 M(-25.4%) | -$202.85 M(+4.6%) |
| Sept 2021 | - | -$53.37 M(-0.9%) | -$193.96 M(+20.2%) |
| June 2021 | - | -$53.87 M(-3.5%) | -$161.40 M(+37.2%) |
| Mar 2021 | - | -$55.80 M(+80.5%) | -$117.59 M(+64.9%) |
| Dec 2020 | -$71.32 M(+183.7%) | -$30.91 M(+48.5%) | -$71.32 M(+39.4%) |
| Sept 2020 | - | -$20.81 M(+106.7%) | -$51.15 M(+36.2%) |
| June 2020 | - | -$10.07 M(+5.7%) | -$37.57 M(+34.3%) |
| Mar 2020 | - | -$9.52 M(-11.4%) | -$27.98 M(+11.3%) |
| Dec 2019 | -$25.14 M(+16.4%) | -$10.75 M(+48.7%) | -$25.14 M(+65.2%) |
| Sept 2019 | - | -$7.23 M(+1409.0%) | -$15.21 M(+23.3%) |
| June 2019 | - | -$479.00 K(-92.8%) | -$12.34 M(-43.9%) |
| Mar 2019 | - | -$6.68 M(+707.9%) | -$21.98 M(+0.5%) |
| Dec 2018 | -$21.60 M | -$827.00 K(-81.0%) | -$21.87 M(-16.7%) |
| Sept 2018 | - | -$4.36 M(-57.0%) | -$26.27 M(+5.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | -$10.12 M(+54.0%) | -$25.03 M(+56.7%) |
| Mar 2018 | - | -$6.57 M(+25.7%) | -$15.98 M(+22.5%) |
| Dec 2017 | -$10.75 M(+766.3%) | -$5.23 M(+67.9%) | -$13.04 M(-230.1%) |
| Sept 2017 | - | -$3.11 M(+192.0%) | $10.02 M(+92.3%) |
| June 2017 | - | -$1.07 M(-70.7%) | $5.21 M(+1355.3%) |
| Mar 2017 | - | -$3.63 M(-120.4%) | $358.00 K(-128.8%) |
| Dec 2016 | -$1.24 M(-24.8%) | $17.83 M(-325.1%) | -$1.24 M(-79.3%) |
| Sept 2016 | - | -$7.92 M(+33.9%) | -$6.00 M(+150.1%) |
| June 2016 | - | -$5.92 M(+13.1%) | -$2.40 M(+45.0%) |
| Mar 2016 | - | -$5.23 M(-140.0%) | -$1.65 M(+0.2%) |
| Dec 2015 | -$1.65 M(-95.0%) | $13.07 M(-402.4%) | -$1.65 M(-92.3%) |
| Sept 2015 | - | -$4.32 M(-16.4%) | -$21.32 M(-22.7%) |
| June 2015 | - | -$5.17 M(-1.1%) | -$27.58 M(-8.8%) |
| Mar 2015 | - | -$5.23 M(-20.8%) | -$30.24 M(-7.9%) |
| Dec 2014 | -$32.85 M(+219.6%) | -$6.60 M(-37.7%) | -$32.85 M(+3.0%) |
| Sept 2014 | - | -$10.59 M(+35.2%) | -$31.88 M(+30.5%) |
| June 2014 | - | -$7.83 M(-0.1%) | -$24.43 M(+37.3%) |
| Mar 2014 | - | -$7.83 M(+39.1%) | -$17.80 M(+73.2%) |
| Dec 2013 | -$10.28 M(+585.6%) | -$5.63 M(+79.6%) | -$10.28 M(+110.0%) |
| Sept 2013 | - | -$3.14 M(+162.2%) | -$4.89 M(+142.1%) |
| June 2013 | - | -$1.20 M(+280.9%) | -$2.02 M(+61.2%) |
| Mar 2013 | - | -$314.00 K(+27.1%) | -$1.25 M(+33.4%) |
| Dec 2012 | -$1.50 M(-61.4%) | -$247.00 K(-6.4%) | -$940.00 K(+35.6%) |
| Sept 2012 | - | -$264.00 K(-38.5%) | -$693.00 K(+61.5%) |
| June 2012 | - | -$429.00 K | -$429.00 K |
| Dec 2011 | -$3.88 M | - | - |
FAQ
- What is Arcturus Therapeutics Holdings annual earnings before interest & taxes?
- What is the all time high annual EBIT for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings annual EBIT year-on-year change?
- What is Arcturus Therapeutics Holdings quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings quarterly EBIT year-on-year change?
- What is Arcturus Therapeutics Holdings TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings TTM EBIT year-on-year change?
What is Arcturus Therapeutics Holdings annual earnings before interest & taxes?
The current annual EBIT of ARCT is -$27.12 M
What is the all time high annual EBIT for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high annual earnings before interest & taxes is $15.17 M
What is Arcturus Therapeutics Holdings annual EBIT year-on-year change?
Over the past year, ARCT annual earnings before interest & taxes has changed by -$40.77 M (-298.78%)
What is Arcturus Therapeutics Holdings quarterly earnings before interest & taxes?
The current quarterly EBIT of ARCT is -$10.74 M
What is the all time high quarterly EBIT for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high quarterly earnings before interest & taxes is $119.43 M
What is Arcturus Therapeutics Holdings quarterly EBIT year-on-year change?
Over the past year, ARCT quarterly earnings before interest & taxes has changed by +$8.58 M (+44.41%)
What is Arcturus Therapeutics Holdings TTM earnings before interest & taxes?
The current TTM EBIT of ARCT is -$21.74 M
What is the all time high TTM EBIT for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high TTM earnings before interest & taxes is $115.70 M
What is Arcturus Therapeutics Holdings TTM EBIT year-on-year change?
Over the past year, ARCT TTM earnings before interest & taxes has changed by -$121.49 M (-121.80%)